33 research outputs found

    Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Get PDF

    Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

    Get PDF
    In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field

    The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study

    Get PDF
    AIM: The SARS-CoV-2 pandemic has provided a unique opportunity to explore the impact of surgical delays on cancer resectability. This study aimed to compare resectability for colorectal cancer patients undergoing delayed versus non-delayed surgery. METHODS: This was an international prospective cohort study of consecutive colorectal cancer patients with a decision for curative surgery (January-April 2020). Surgical delay was defined as an operation taking place more than 4 weeks after treatment decision, in a patient who did not receive neoadjuvant therapy. A subgroup analysis explored the effects of delay in elective patients only. The impact of longer delays was explored in a sensitivity analysis. The primary outcome was complete resection, defined as curative resection with an R0 margin. RESULTS: Overall, 5453 patients from 304 hospitals in 47 countries were included, of whom 6.6% (358/5453) did not receive their planned operation. Of the 4304 operated patients without neoadjuvant therapy, 40.5% (1744/4304) were delayed beyond 4 weeks. Delayed patients were more likely to be older, men, more comorbid, have higher body mass index and have rectal cancer and early stage disease. Delayed patients had higher unadjusted rates of complete resection (93.7% vs. 91.9%, P = 0.032) and lower rates of emergency surgery (4.5% vs. 22.5%, P < 0.001). After adjustment, delay was not associated with a lower rate of complete resection (OR 1.18, 95% CI 0.90-1.55, P = 0.224), which was consistent in elective patients only (OR 0.94, 95% CI 0.69-1.27, P = 0.672). Longer delays were not associated with poorer outcomes. CONCLUSION: One in 15 colorectal cancer patients did not receive their planned operation during the first wave of COVID-19. Surgical delay did not appear to compromise resectability, raising the hypothesis that any reduction in long-term survival attributable to delays is likely to be due to micro-metastatic disease

    Diagnostic labels of NANDA-I in a southern region of Spain

    No full text
    Objetivo: determinar a incidência das etiquetas diagnósticas da NANDA-I (North American Nursing Diagnosis Association - International) e estabelecer a distribuição dos episódios assistenciais e de suas respectivas etiquetas em função de variáveis sociodemográficas (idade e sexo). Método: estudo epidemiológico descritivo, de corte transversal, das etiquetas da NANDA-I, de desenho ecológico. A distribuição das etiquetas segundo sexo e idade foi analisada; as frequências correspondentes foram calculadas e as taxas de incidência com dados agregados para os episódios assistenciais por etiqueta foram computadas Resultados: o número total de episódios assistenciais do estudo foi de 9.928 (41,65% homens e 58,35% mulheres). As etiquetas identificadas nesses episódios foram 16.456 (7.084 de homens e 9.372 de mulheres), com uma média de 1,7 etiquetas por episódio; das 216 etiquetas propostas pela NANDA-I, na sua classificação 2012-14, foram utilizadas 152, o que representou 70,4%. As etiquetas com maiores taxas de incidência por mil habitantes foram: Ansiedade, Disposição para melhorar os conhecimentos e Risco de infecção Conclusões: o estudo permitiu detectar, por meio da NANDA-I, as respostas aos problemas de saúde de maior incidência nos usuários atendidos.Objective: to determine the incidence of NANDA-I diagnostic labels (North American Nursing Diagnosis Association-International) and to establish the distribution of cases of assistance and the associated labels, according to sociodemographic variables (age and sex). Method: descriptive, cross-sectional epidemiological study of labels of NANDA-I, under ecological design. The distribution of labels was analyzed according to sex and age; the corresponding frequencies were calculated and for each label the incidence were calculated rates with aggregate data from the attended cases. Results: the total number of cases of care under study was 9,928 (41.65% men and 58.35% women). The identified labels were 16,456 (7,084 men and 9,372 women); average of 1.7 labels per case of care; Out of 216 labels proposed by NANDA-I, in its 2012-14 classification, 152 were used, representing 70.4%. The labels with the highest incidence rates per thousand inhabitants were: Anxiety, Willingness to Improve Knowledge and Risk of Infection. Conclusions: the study allowed detecting, through NANDA-I, the answers to the health problems of greater incidence in the users attended.Objetivo: determinar la incidencia de las etiquetas diagnósticas de la NANDA-I (North American Nursing Diagnosis Association-International) y establecer la distribución de los episodios asistenciales y de sus respectivas etiquetas, en función de variables sociodemográficas (edad y sexo). Método: estudio epidemiológico descriptivo y de corte transversal de las etiquetas de la NANDA-I, bajo diseño ecológico. Se analizó la distribución de las etiquetas según sexo y edad, se calcularon las frecuencias correspondientes y se computaron las tasas de incidencia con datos agregados para los episodios asistenciales por etiqueta. Resultados: el número total de episodios asistenciales del estudio fue de 9.928 (41,65% hombres y 58,35% mujeres). Las etiquetas identificadas en los episodios fueron 16.456 (7.084 hombres y 9.372 mujeres), con un promedio de 1,7 etiquetas por episodio; de las 216 etiquetas propuestas por la NANDA-I, en su clasificación 2012-14, se utilizaron 152, lo que representó 70,4%. Las etiquetas con mayores tasas de incidencia por mil habitantes fueron: Ansiedad, Disposición para mejorar los conocimientos y Riesgo de infección. Conclusiones: el estudio permitió detectar, a través de la NANDA-I, las respuestas a los problemas de salud de mayor incidencia en los usuarios atendidos

    The health of the Roma people: a review of the published literature

    No full text
    BACKGROUND—The Roma people originated in northern India and have been known in Europe for nearly a thousand years. For much of that time they have been the subjects of discrimination and oppression, culminating in the extermination of half a million Roma in the Nazi death camps. While it is widely believed that the health of Roma people is often poorer than the majority population, these inequalities remain largely unresearched.
METHODS—Published literature on the health of the Roma people was identified using Medline. Opinion pieces were excluded, as were papers relating to anthropometry and to genetic markers. The resultant papers were analysed by country of study and by disease type or care group.
RESULTS—Some 70% of papers identified related to just three countries; Spain and the Czech and Slovak Republics. Much literature concentrates upon communicable disease or reproductive health. The limited evidence suggests increased morbidity from non-communicable disease, but there is little published on this topic. Evidence on health care, though fragmentary, suggests poorer access to health services and uptake of preventative care.
DISCUSSION—Published research on the health needs of the Roma population is sparse. The topics that have received attention suggest a focus on concepts of contagion or social Darwinism, indicating a greater concern with the health needs of the majority populations with which they live. There is a need for both further research into the health of Roma people; with particular emphasis on non-communicable disease; and also for interventions that improve Roma health. Such research must, however, be handled with sensitivity, recognising the social and political context of the society concerned.


Keywords: gypsies; inequalities; ethnicity; social exclusio
    corecore